Identification of a Novel Rb-regulated Gene Associated with the Cell Cycle

  • Sung, Young Hoon (Department of Biochemistry and Yonsei Laboratory Animal Research Center, Yonsei University) ;
  • Kim, Hye Jin (Department of Biochemistry and Yonsei Laboratory Animal Research Center, Yonsei University) ;
  • Lee, Han-Woong (Department of Biochemistry and Yonsei Laboratory Animal Research Center, Yonsei University)
  • Received : 2007.06.20
  • Accepted : 2007.06.26
  • Published : 2007.12.31

Abstract

The retinoblastoma (Rb) gene is one of the most important genes in cell cycle regulation and tumorigenesis. Homozygosity for a germ-line Rb mutation results in embryonic lethality and evokes developmental defects associated with inappropriate S-phase entry and high levels of apoptosis. Although Rb has been extensively studied, more target genes need to be identified and characterized to unravel the precise mechanism of Rb function. In order to identify Rb-regulated genes, we analyzed the gene expression profile of Rb-deficient mouse embryo fibroblasts (MEFs), and identified an unknown gene, RbEST47, that is transcriptionally upregulated in Rb-deficient MEFs. This gene is conserved from fruitfly to human. It is expressed in brain, lung, kidney, and testis, and is located on mouse chromosome 2. This region is syntenic to human chromosome 9q34.3, which frequently exhibits loss of heterozygosity in neoplastic diseases. RbEST47 was considerably down-regulated in immortalized cells, and showed cell cycle-dependent expression, suggesting important roles in S and/or G2.

Keywords

Acknowledgement

Supported by : Korea Research Foundation

References

  1. Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., et al. (1996) Involvement of the cyclin-dependent kinase inhibitor $p16^{INK4a}$ in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93, 13742−13747
  2. Baba, M., Hirai, S., Kawakami, S., Kishida, T., Sakai, N., et al. (2001) Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene 20, 2727−2736
  3. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., et al. (1998) $p14^{ARF}$ links the tumour suppressors RB and p53. Nature 395, 124−125 https://doi.org/10.1038/25870
  4. Brugarolas, J., Bronson, R. T., and Jacks, T. (1998) p21 is a critical CKD2 regulator essential for proliferation control in Rb-deficient cells. J. Cell Biol. 141, 503−514
  5. Clarke, A. R., Maandag, E. R., Roon, M., Lugt, N. M., Valk, M., et al. (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359, 328−330
  6. DeGregori, J., Kowalik, T., and Nevins, J. R. (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215−4224
  7. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes. Dev. 12, 2245−2262
  8. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., et al. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487−497
  9. Frolov, M. V. and Dyson, N. J. (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173−2181
  10. Gartel, A. L., Goufman, E., Tevosian, S. G., Shih, H., Yee, A. S., et al. (1998) Activation and repression of $p21^{WAF1/CIP1}$transcription by RB binding proteins. Oncogene 17, 3463−3469
  11. Habuchi, T., Devlin, J., Elder, P. A., and Knowles, M. A. (1995) Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 11, 1671−1674
  12. Hahn, W. C. (2002) Immortalization and transformation of human cells. Mol. Cells 13, 351−361
  13. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., et al. (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859−867
  14. Herrera, R. E., Sah, V. P., Williams, B. O., Makela, T. P., Weinberg, R. A., et al. (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rbdeficient fibroblasts. Mol. Cell. Biol. 16, 2402−2407
  15. Hickman, E. S., Moroni, M. C., and Helin, K. (2002) The role of p53 and pRB in apoptosis and cancer. Curr. Opin. Genet. Dev. 12, 60−66
  16. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., et al. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993−1006
  17. Honda, R. and Yasuda, H. (1999) Association of $p19^{ARF}$ with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22−27
  18. Hornigold, N., Devlin, J., Davies, A. M., Aveyard, J. S., Habuchi, T., et al. (1999) Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18, 2657−2661
  19. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., et al. (1992) Effects of an Rb mutation in the mouse. Nature 359, 295−300 https://doi.org/10.1038/359300a0
  20. Kalma, Y., Marash, L., Lamed, Y., and Ginsberg, D. (2001) Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2. Oncogene 20, 1379−1387
  21. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331− 342
  22. Knudsen, E. S., Buckmaster, C., Chen, T. T., Feramisco, J. R., and Wang, J. Y. (1998) Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev. 12, 2278−2292
  23. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., et al. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288−294
  24. Macleod, K. F., Hu, Y., and Jacks, T. (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15, 6178−6188
  25. Morgenbesser, S. D., Williams, B. O., Jacks, T., and DePinho, R. A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371, 72−74
  26. Moroni, M. C., Hickman, E. S., Lazzerini, D. E., Caprara, G., Colli, E., et al. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552−558
  27. Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., et al. (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4, 859−864
  28. Polager, S. and Ginsberg, D. (2003) E2F mediates sustained G2 arrest and down-regulation of stathmin and AIM-1 expression in response to genotoxic stress. J. Biol. Chem. 278, 1443−1449
  29. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993−1000
  30. Reddel, R. R. (2000) The role of senescence and immortalization in carcinogenesis. Carcinogenesis 21, 477−484
  31. Reznikoff, C. A., Yeager, T. R., Belair, C. D., Savelieva, E., Puthenveettil, J. A., et al. (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56, 2886−2890
  32. Rogers, S., Wells, R., and Rechsteiner, M. (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364−368
  33. Serrano, M., Hannon, G. J., and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704−707
  34. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., et al. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27−37
  35. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and $p16^{INK4a}$. Cell 8, 593−602
  36. Sherr, C. J. (2001) The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2, 731−737 https://doi.org/10.1038/35093526
  37. Srinivasan, S. V., Mayhew, C. N., Schwemberger, S., Zagorski, W. A., and Knudsen, E. S. (2007) RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors. J. Biol. Chem. 282, 23867−23877
  38. Suzuki, K., Ogura, T., Yokose, T., Nagai, K., Mukai, K., et al. (1998) Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int. J. Cancer 79, 384−389
  39. Takamochi, K., Ogura, T., Suzuki, K., Kawasaki, H., Kurashima, Y., et al. (2001) Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am. J. Pathol. 159, 1941− 1948
  40. Tanaka, M., Omura, K., Watanabe, Y., Oda, Y., and Nakanishi, I. (1994) Prognostic factors of colorectal cancer: K-ras mutation, overexpression of the p53 protein, and cell proliferative activity. J. Surg. Oncol. 57, 57−64
  41. Todaro, G. J. and Green, H. (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299−313
  42. Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., et al. (1998) Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293−304
  43. Tsai, K. Y., MacPherson, D., Rubinson, D. A., Crowley, D., and Jacks, T. (2002) ARF is not required for apoptosis in Rb mutant mouse embryos. Curr. Biol. 12, 159−163 https://doi.org/10.1016/S0960-9822(02)00731-5
  44. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar- Sagi, D. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1, 20−26
  45. Yoo, Y. A., Kim, M. J., Park, J. K., Chung, Y. M., Lee, J. H., et al. (2005) Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. Mol. Cell. Biol. 25, 6603−6616
  46. Ziebold, U., Reza, T., Caron, A., and Lees, J. A. (2001) E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386−391
  47. Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., et al. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424−2433